Five-year outcomes from the randomized, phase 3 trials CheckMate 017/057: nivolumab vs docetaxel in previously treated NSCLC. (January 2020)

• Record Type: Journal Article
• Authors: Lind, M.; Gettinger, S.; Borghaei, H.; Brahmer, J.; Chow, L.; Burgio, M.; De Castro Carpeno, J.; Pluzanski, A.; Arrieta, O.; Frontera, O. Aren; Chiari, R.; Butts, C.; Wojcik-Tomaszewska, J.; Coudert, B.; Garassino, M.; Ready, N.; Felip, E.; Garcia, M. Alonso; Waterhouse, D.; Domine, M.; Barlesi, F.; Antonia, S.; Wohlleber, M.; Gerber, D.; Czyzewicz, G.; Spigel, D.; Crino, L.; Eberhardt, W.; Li, A.; Marimuthu, S.; Vokes, E.;
• Is Part Of: Lung cancer. Volume 139(2020)Supplement 1
• Page Start: S49
• Page End: S50
• Publication Date: 2020-01
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/S0169-5002(20)30141-0
• Languages: English
• ISSNs: 0169-5002